Evaluating atezolizumab in patients with urinary tract squamous cell carcinoma (AURORA): study protocol for a single arm, open-label, multicentre, phase II clinical trial

por Crabb, Simon, Wickens, Robin, Jane-Bibby, Sarah, Dunkley, Denise, Lawrence, Megan, Knight, Allen, Jones, Robert, Birtle, Alison, Huddart, Robert, Linch, Mark, Martin, Jonathan, Coleman, Adam, Boukas, Konstantinos, Markham, Hannah, Griffiths, Gareth
Publicado 2023

Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial

por Santer, Miriam, Lawrence, Megan, Renz, Susanne, Eminton, Zina, Stuart, Beth, Sach, Tracey H, Pyne, Sarah, Ridd, Matthew J, Francis, Nick, Soulsby, Irene, Thomas, Karen, Permyakova, Natalia, Little, Paul, Muller, Ingrid, Nuttall, Jacqui, Griffiths, Gareth, Thomas, Kim S, Layton, Alison M
Publicado 2023

An Open Label, Adaptive, Phase 1 Trial of High‐Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS‐CoV‐2

por Walker, Lauren E., FitzGerald, Richard, Saunders, Geoffrey, Lyon, Rebecca, Fisher, Michael, Martin, Karen, Eberhart, Izabela, Woods, Christie, Ewings, Sean, Hale, Colin, Rajoli, Rajith K. R., Else, Laura, Dilly‐Penchala, Sujan, Amara, Alieu, Lalloo, David G., Jacobs, Michael, Pertinez, Henry, Hatchard, Parys, Waugh, Robert, Lawrence, Megan, Johnson, Lucy, Fines, Keira, Reynolds, Helen, Rowland, Timothy, Crook, Rebecca, Okenyi, Emmanuel, Byrne, Kelly, Mozgunov, Pavel, Jaki, Thomas, Khoo, Saye, Owen, Andrew, Griffiths, Gareth, Fletcher, Thomas E.
Publicado 2021